FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN

 FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN

22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products,

 » Read More